ArticleBreast cancer research : BCR2011

Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib.

Cristina Oliveras-Ferraros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.